Radiopharmaceutical deliveries to Womak Army Medical Center, Ft. Bragg, NC

SOL #: W81K0426QA047Sources Sought

Overview

Buyer

DEPT OF DEFENSE
Dept Of The Army
W40M MRCO EAST
FORT BELVOIR, VA, 22060-5580, United States

Place of Performance

Fort Bragg, NC

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
May 19, 2026
2
Response Deadline
May 29, 2026, 5:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of the Army, through Womack Army Medical Center (WAMC), is conducting a Sources Sought to identify qualified vendors for Radiopharmaceutical deliveries to Fort Bragg, NC. This market research aims to gather information on industry capabilities to inform a future procurement strategy, including the potential for a small business set-aside. Responses are due by May 29, 2026, at 1:00 PM EST.

Scope of Work

Contractors will be required to provide various radiopharmaceuticals to the Nuclear Medicine Services, Department of Radiology, WAMC. Deliveries will be on an as-needed basis, with doses provided in individually shielded plastic syringes. Key delivery types include:

  • Normal Duty Deliveries: Scheduled for 6:30 AM and 1:00 PM (M-F), and 7:30 AM (Sat, Sun, holidays).
  • Additional Normal Duty Deliveries: Extra deliveries during normal hours.
  • Emergency Deliveries: Outside normal duty hours, requiring a response within two hours.
  • Stat Deliveries: Immediate response, within 30 minutes of order placement.

Specific radiopharmaceuticals include Tc Ceretec, 111 Indium Labeled Leukocytes (requiring blood sample pickup and return of labeled cells), 99m Tc Pertechnetate, Y-90 therapy doses, and a comprehensive list of other diagnostic and therapeutic agents. Contractors must be licensed by the United States Nuclear Regulatory Commission (NRC), the Food and Drug Administration (FDA), and the state of North Carolina for manufacturing and distribution.

Contract & Timeline

  • Type: Sources Sought / Market Research
  • NAICS: 325412 Pharmaceutical Preparation Manufacturing (Size Standard: 1,300 employees)
  • PSC: 6505 Drugs and Biologicals
  • Set-Aside: None specified (purpose is to determine if one is appropriate)
  • Response Due: May 29, 2026, 1:00 PM EST
  • Published: May 19, 2026

Evaluation

Responses will be used solely for market research to identify interested and capable contractors and to help determine the appropriate procurement strategy, including any potential small business set-aside.

Additional Notes

This is a Sources Sought Notice for information gathering only and is not a solicitation or a guarantee of a future contract award. The Government will not pay for any information submitted in response to this notice. Interested contractors should submit company details, UEI, business type, applicable NAICS, a one-page capability summary, and a statement acknowledging required licenses to Victoria Manigault at victoria.g.manigault.civ@mail.gov.

People

Points of Contact

Victoria ManigaultPRIMARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Sources Sought
Posted: May 19, 2026
Radiopharmaceutical deliveries to Womak Army Medical Center, Ft. Bragg, NC | GovScope